The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The importance of norepinephrine in depression
Open accessAbstract
Depression is one of the most common psychological diseases with significant potential morbidity and mortality. Although the underlying pathophysiology of depression has not been clearly defined, preclinical and clinical evidence suggest disturbances in serotonin (5-HT), norepinephrine (NE), and dopamine (DA) neurotransmission in the central nervous system. Virtually all currently available antidepressants act on one or more of the following mechanisms: inhibition of reuptake of 5-HT or NE (and DA), antagonism of inhibitory presynaptic 5-HT or NE receptors, or inhibition of monoamine oxidase. All of these mechanisms result in an enhanced neurotransmission of 5-HT and/or NE. Evidence for the involvement of NE in depression is abundant, and recent studies on neuronal pathways and symptoms highlight the specific role of NE in this disorder. NE plays a determinant role in executive functioning regulating cognition, motivation, and intellect, which are fundamental in social relationships. Social dysfunction is possibly one of the most important factors affecting the quality of life in depressed patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pathophysiology of depression is complex and includes social environmental stress factors; genetic and biological processes, such as the overdrive of the HPA axis, inflammation (31), and disturbances in monamine neurotransmission as described above (91).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [91]
In the citing paper
“Several lines of evidence suggest that NE is a neurotransmitter of major importance in the pathophysiology and treatment of depressive disorders (91).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [91]
In the citing paper
“Thus, experimental depletion of NE in the brain led to a return of depressive symptoms after successful treatment with NE antidepressant drugs (91).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Hippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
(2008) · Cited by 889
Ruhé, H. G., Mason, N. S., & Schene, A. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001949 · Cited by 861
Eyding, D., Lelgemann, M., Grouven, U., Härter, M. C., Kromp, M., Kaiser, T., Kerekeş, M., Gerken, M., & Wieseler, B. (2010) · BMJ · doi:10.1136/bmj.c4737 · Cited by 600
Drevets, W. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00102-5 · Cited by 581
Increased Serotonin2 and β-Adrenergic Receptor Binding in the Frontal Cortices of Suicide Victims
Mann, J. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800100048007 · Cited by 547
Relationship of neurotransmitters to the symptoms of major depressive disorder.
Nutt, D. (2008) · PubMed · Cited by 470
Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression
Klimek, V., Stockmeier, C. A., Overholser, J. C., Meltzer, H. Y., Kalka, S., Dilley, G. E., & Ordway, G. A. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08451.1997 · Cited by 445
Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106069938 · Cited by 366
Papakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.027 · Cited by 308
Role of norepinephrine in depression.
Delgado, P. L., & Moreno, F. A. (2000) · PubMed · Cited by 250
The Molecular Neurobiology of Depression
Shelton, R. C. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.12.005 · Cited by 244
Serotonin and depression: pathophysiological mechanism or marketing myth?
Cowen, P. J. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.004 · Cited by 218
Boeker, H. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-18088 · Cited by 208
Stahl, S. M., Zhang, L., Damatarca, C., & Grady, M. M. (2003) · PubMed · Cited by 202
Frisch, A., Postilnick, D., Rockah, R., Michaelovsky, E., Postilnick, S., Birman, E., Laor, N., Rauchverger, B., Kreinin, A., Poyurovsky, M., et al. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000536 · Cited by 180
Estrogen-related Mood Disorders
Douma, S. L., Husband, C., OʼDonnell, M. E., Barwin, B. N., & Woodend, A. (2005) · Advances in Nursing Science · doi:10.1097/00012272-200510000-00008 · Cited by 165
Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression
Ohara, K., Nagai, M., Suzuki, Y., & Ohara, K. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00009 · Cited by 145
Elevated agonist binding to α2-adrenoceptors in the locus coeruleus in major depression
Ordway, G. A., Schenck, J. E., Stockmeier, C. A., May, W., & Klimek, V. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01728-6 · Cited by 134
Escribá, P. V., Ozaita, A., & Garcı́a-Sevilla, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300459 · Cited by 125
Transient Depressive Relapse Induced by Catecholamine Depletion
Berman, R., Narasimhan, M., Miller, H., Anand, A., Cappiello, A., Oren, D. A., Heninger, G. R., & Charney, D. S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.395 · Cited by 118
Haenisch, B., Bilkei‐Gorzo, A., Caron, M. G., & Bönisch, H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06345.x · Cited by 113
Kunugi, H., Vallada, H., Hoda, F., Kirov, G., Gill, M., Aitchison, K. J., Ball, D., Arranz, M. J., Murray, R. M., & Collier, D. A. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00366-6 · Cited by 106
Wang, Y.-M., Xu, F., Gainetdinov, R. R., & Caron, M. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00245-0 · Cited by 82
Reboxetine: additional benefits to the depressed patient.
Sa, M. (1997) · PubMed · Cited by 73
The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women
Lasiuk, G. C., & Hegadoren, K. (2007) · Biological Research For Nursing · doi:10.1177/1099800407305600 · Cited by 68
Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
Massana, J. (1998) · PubMed · Cited by 66
Association between Catechol-O-Methyltransferase Functional Polymorphism and Male Suicide Completers
Ono, H., Shirakawa, O., Nushida, H., Ueno, Y., & Maeda, K. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300470 · Cited by 65
Antidepressant effects of estrogens: a basic approximation
Estrada-Camarena, E. M., López‐Rubalcava, C., Vega‐Rivera, N. M., Récamier-Carballo, S., & Fernández‐Guasti, A. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833db7e9 · Cited by 58
Oestrogen, brain function, and neuropsychiatric disorders
Cutter, W. J. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.837 · Cited by 47
Symptoms and Circuits, Part 3: Schizophrenia
Stahl, S. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0102 · Cited by 46
α2-Adrenoceptor Functionality in Postmortem Frontal Cortex of Depressed Suicide Victims
Valdizán, E. M., Dı́ez-Alarcia, R., González‐Maeso, J., Pilar-Cuéllar, F., Garcı́a-Sevilla, J. A., Meana, J. J., & Pazos, Á. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.023 · Cited by 41
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
Briley, M. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s13171 · Cited by 38
Self-citationSymptoms and Circuits, Part 2: Anxiety Disorders
Stahl, S. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1201 · Cited by 35
Maes, M. H. J., Gastel, A. V., Delmeire, L., & Meltzer, H. Y. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00002-x · Cited by 35
Gurguis, G. N. M., Vo, S. P., Griffith, J. M., & Rush, A. J. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00103-1 · Cited by 35
The under-recognized role of dopamine in the treatment of major depressive disorder
Montgomery, S. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f2b3cb · Cited by 33
Human Genetics and Pharmacology of Neurotransmitter Transporters
Lin, Z., & Madras, B. K. (2006) · Handbook of experimental pharmacology · doi:10.1007/3-540-29784-7_16 · Cited by 29
Symptoms and Circuits, Part 1: Major Depressive Disorder
Stahl, S. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1101 · Cited by 21
The management of fatigue in depressed patients.
Marín, H., & Menza, M. A. (2005) · PubMed · Cited by 19
[Executive function disorders].
Papazian, Ó., Alfonso, I., & Luzondo, R. J. (2006) · PubMed · Cited by 15
Endocrine disturbances and psychiatric disorders
Monteleone, P. (2001) · Current Opinion in Psychiatry · doi:10.1097/00001504-200111000-00020 · Cited by 14
Getting the balance right: Established and emerging therapies for major depressive disorders
Vezmar (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s10485 · Cited by 12
Flagged first, then by citations
Cited by
Sorted by citations
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“Thus, experimental depletion of NE in the brain led to a return of depressive symptoms after successful treatment with NE antidepressant drugs (91).”
BackgroundA genetically encoded fluorescent sensor for rapid and specific in vivo detection of norepinephrine
Feng, J., Zhang, C., Lischinsky, J. E., Jing, M., Zhou, J., Wang, H., Zhang, Y., Dong, A., Wu, Z., Wu, H., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.037 · Cited by 545
McGuinness, A. J., Davis, J. A., Dawson, S. L., Loughman, A., Collier, F., O’Hely, M., Simpson, C. A., Green, J., Marx, W., Hair, C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01456-3 · Cited by 502
Behl, T., Kaur, D., Sehgal, A., Singh, S., Sharma, N., Zengin, G., Andronie-Cioară, F. L., Toma, M. M., BUNGAU, S. G., & Bumbu, A. G. (2021) · Molecules · doi:10.3390/molecules26123724 · Cited by 340
DSM-5 Criteria and Depression Severity: Implications for Clinical Practice
Tolentino, J. C., & Schmidt, S. L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00450 · Cited by 311
Metadata
- Authors
- Briley, M., & Chantal, M.
- Corresponding author
- Briley, Mike
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2011-05
- Volume
- 7
- Issue
- Suppl 1
- Pages
- 9
- ISSN
- 1176-6328 (ISSN-L)
- PMC
- PMC3131098
- OpenAlex
- W2006526695
- Cited by
- 373
- References
- 49
- Citations by year
- 2026: 9 · 2025: 32 · 2024: 37 · 2023: 40 · 2022: 27 · 2021: 54 · 2020: 31 · 2019: 34 · 2018: 31 · 2017: 21 · 2016: 17 · 2015: 14 · 2014: 13 · 2013: 7 · 2012: 4
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- norepinephrine, depression, monoamine neurotransmission, serotonin, dopamine, antidepressant mechanism, norepinephrine reuptake inhibition, monoamine oxidase inhibition, executive function, motivation, social dysfunction, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
